WOLFENBÜTTEL, Germany & BEVERLY, Mass.--(BUSINESS WIRE)--BIOBASE announced today that it is entering the Next Generation Sequencing (NGS) market with the launch of a new solution. Genome Trax™ enables researchers to identify genome variations of functional significance by mapping them to known elements such as gene regulatory sites and disease-linked mutations. Researchers interpreting large numbers of sequence variants can now easily distinguish those variants that have biological importance. Genome Trax contains unique, manually-curated data from peer-reviewed literature, and is designed for seamless integration into existing NGS analysis workflows.
